デフォルト表紙
市場調査レポート
商品コード
1658778

動物バイオテクノロジーの世界市場レポート 2025年

Animal Biotechnology Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
動物バイオテクノロジーの世界市場レポート 2025年
出版日: 2025年02月18日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物バイオテクノロジーの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.2%で486億8,000万米ドルに成長します。予測期間の成長は、耐病性株の開発、バイオ医薬品の生産、細胞ベースの食肉生産、世界の食糧安全保障への懸念、規制当局の支援、一般大衆と消費者の受容に起因すると考えられます。予測期間における主な動向には、ゲノム編集技術、動物幹細胞技術、動物におけるバイオ医薬品生産、バイオバンキングと遺伝資源保存、クリスプルを用いた療法の出現、バイオセキュリティと疾病監視が含まれます。

動物の健康と福祉に対する意識の高まりが、今後の動物バイオテクノロジー市場の成長を促進すると予想されます。動物の健康と福祉には、人と動物との相互作用や、動物が適切かつ思いやりをもって扱われることを保証する責任が含まれます。その中で動物バイオテクノロジーは、成長、繁殖の質、栄養、飼料効率、食の安全性などを向上させることで動物の生産性を高め、資源の有効活用につなげるという重要な役割を担っています。例えば、2023年5月、動物愛護協会は「More Than a Pet」キャンペーンを開始し、特に十分なサービスを受けていない地域社会における、動物病院への公平なアクセスの重要性を強調しました。このイニシアチブを通じて、2023年には14,800頭以上のペットが、低資源地域における動物福祉の向上を目的とした地域支援プログラムを通じて、64,000件のサービスを受けた。このキャンペーンは、こうした恵まれない地域の動物たちの福祉を向上させるために、必要不可欠な獣医療と支援を提供することを重視しています。このように、動物の健康と福祉に対する意識の高まりが、動物バイオテクノロジー市場の成長を後押ししています。

家畜人口の拡大は、動物バイオテクノロジー分野の成長を促進する上で重要な役割を果たしています。家畜は、農業や経済目的で飼育される家畜を含み、動物バイオテクノロジーの研究開発のための多様なプールを提供します。家畜の数が増えることで、研究者は新しいバイオテクノロジーの解決策を探求し、試験し、開発するために、より広範な生物種を得ることができます。例えば英国では、2021年から2022年にかけて牛と子牛の頭数が0.3%増加し、960万頭に達したと記録されています。この増加は、動物バイオテクノロジー領域における調査とイノベーションの可能性を意味し、その成長にプラスの影響を与えます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の動物バイオテクノロジーPESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の動物バイオテクノロジー市場:成長率分析
  • 世界の動物バイオテクノロジー市場の実績:規模と成長, 2019-2024
  • 世界の動物バイオテクノロジー市場の予測:規模と成長, 2024-2029, 2034F
  • 世界の動物バイオテクノロジー総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の動物バイオテクノロジー市場:製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断検査
  • ワクチン
  • 薬剤
  • 生殖と遺伝
  • 飼料添加物
  • 世界の動物バイオテクノロジー市場:動物タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • コンパニオン
  • 家畜
  • 世界の動物バイオテクノロジー市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 動物の疾患診断
  • 動物の病気治療
  • 動物の予防ケア
  • 医薬品開発
  • その他の用途
  • 世界の動物バイオテクノロジー市場:最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ラボ
  • ポイントオブケア検査/社内検査
  • 動物病院と診療所
  • その他の用途
  • 世界の動物バイオテクノロジー市場:診断検査のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 免疫診断検査
  • 分子診断検査
  • 生化学診断検査
  • 世界の動物バイオテクノロジー市場:ワクチンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 不活化ワクチン
  • 生弱毒化ワクチン
  • 組み換えワクチン
  • 世界の動物バイオテクノロジー市場:薬物のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗菌薬
  • 抗炎症薬
  • ホルモン剤
  • 世界の動物バイオテクノロジー市場:生殖と遺伝のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 遺伝子検査サービス
  • 人工授精製品
  • 胚移植技術
  • 世界の動物バイオテクノロジー市場:飼料添加物のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • プロバイオティクス
  • 酵素
  • 栄養補助食品

第7章 地域別・国別分析

  • 世界の動物バイオテクノロジー市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の動物バイオテクノロジー市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 動物バイオテクノロジー市場:競合情勢
  • 動物バイオテクノロジー市場:企業プロファイル
    • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Biogenesis Bago SA Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Virbac Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Elanco Animal Health Incorporated
  • Randox Laboratories Ltd.
  • Santa Cruz Biotechnology Inc.
  • IDEXX Laboratories Inc.
  • IDVet
  • Heska Corporation
  • INDICAL BIOSCIENCE GmbH
  • BioChek BV
  • Ceva Sante Animale
  • Dalan Animal Health
  • Vetigenics
  • Vetoquinol S.A.
  • Neogen Corporation
  • Abaxis Inc.
  • Henry Schein Animal Health

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 動物バイオテクノロジー市場2029:新たな機会を提供する国
  • 動物バイオテクノロジー市場2029:新たな機会を提供するセグメント
  • 動物バイオテクノロジー市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r22362

Animal biotechnology involves the application of science and engineering techniques to modify living organisms for the benefit of humans and other animals. This field utilizes genetic engineering to modify the genome of animals, with applications ranging from pharmaceuticals and industrial processes to agriculture.

The main products of animal biotechnology include diagnostics tests, vaccines, drugs, reproductive and genetic technologies, as well as feed additives for animals such as companion and livestock. Diagnostics tests are a set of techniques used to diagnose diseases or conditions in organisms. Animal biotechnology is applied in various areas, including the diagnosis and treatment of animal diseases, preventive care, drug development, and other applications. These products are utilized in laboratories, point-of-care testing (in-house testing), veterinary hospitals and clinics, and other end-use settings.

The animal biotechnology market research report is one of a series of new reports from The Business Research Company that provides animal biotechnology market statistics, including animal biotechnology industry global market size, regional shares, competitors with an Critical infrastructure protection market share, detailed animal biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the animal biotechnology industry. This animal biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal biotechnology market size has grown strongly in recent years. It will grow from $30.33 billion in 2024 to $32.97 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to genetic improvement, increased agricultural productivity, vaccines and therapeutics, environmental sustainability, feed efficiency, nutritional enhancement, reduced environmental impact.

The animal biotechnology market size is expected to see rapid growth in the next few years. It will grow to $48.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of disease-resistant strains, biopharmaceutical production, cell-based meat production, global food security concerns, regulatory support, public and consumer acceptance. Major trends in the forecast period include genome editing technologies, genome editing technologies, animal stem cell technology, biopharmaceutical production in animals, biobanking and genetic resource preservation, emergence of Crispr-based therapies, biosecurity and disease surveillance.

The increasing awareness of animal health and welfare is anticipated to drive the growth of the animal biotechnology market in the future. Animal health and welfare encompass the interactions between people and animals and the responsibility to ensure that animals are treated properly and compassionately. Within this context, animal biotechnology plays a significant role in enhancing animal productivity by improving growth, reproductive quality, nutrition, feed efficiency, food safety, and other factors, leading to more effective resource utilization. For example, in May 2023, the Humane Society launched the "More Than a Pet" campaign to highlight the importance of equitable access to veterinary care, particularly for underserved communities. Through this initiative, over 14,800 pets received 64,000 services in 2023 via community outreach programs designed to enhance animal welfare in low-resource areas. The campaign emphasizes providing essential veterinary care and support to improve the well-being of animals in these underserved regions. Thus, the rising awareness of animal health and welfare is propelling the growth of the animal biotechnology market.

The expanding livestock population plays a crucial role in propelling the growth of the animal biotechnology sector. Livestock, encompassing domesticated animals raised for agricultural and economic purposes, provides a diverse pool for research and development endeavors within animal biotechnology. The increasing livestock numbers offer researchers a broader spectrum of species to explore, test, and develop new biotechnological solutions. For example, in the UK, there was a recorded rise of 0.3% in the cattle and calves population from 2021 to 2022, amounting to 9.6 million animals. This increase signifies the potential for research and innovation within the animal biotechnology domain, thereby influencing its growth positively.

Within the animal biotechnology market, product innovation stands as a significant trend. Key industry players are heavily invested in developing pioneering goods, such as the employment of virus-like particle (VLP) technology for vaccine development. For instance, in April 2022, Cadila Pharmaceuticals, an India-based multinational pharmaceutical company, introduced ThRabis, a three-dose rabies vaccine prepared using virus-like particle technology. Utilizing recombinant nanoparticle-based rabies G protein, ThRabis(R) is designed to generate antibodies that neutralize the rabies virus and impede its attachment to cells, thereby providing protection against rabies. This approach illustrates a safer and cost-effective vaccine development method that holds promise within the animal biotechnology realm.

Major companies in the animal biotechnology sector are investing in innovative technological solutions, such as the development of the Animal Biotech Resource Page, to bolster their market position. This resource page serves as a comprehensive public library gathering animal biotechnology resources obtained from global workshops. For instance, the International Service for the Acquisition of Agri-biotech Applications (ISAAA), a non-profit organization based in the United States, launched the Animal Biotech Resource Page in June 2023. This platform offers a wide array of materials, including presentation slides, podcasts, videos, and workshop content, covering the latest advancements in the sector and pertinent regulatory strategies. These global forums facilitate discussions and consensus-building on various subjects. The primary objective of the Animal Biotech Resource Page is to provide researchers, regulators, students, and key stakeholders within the animal biotech field with ongoing opportunities for learning and discourse. By fostering a deeper understanding of the technology, this initiative aims to maximize its benefits for both the environment and society.

Zoetis Inc., a US-based pharmaceutical company, made a strategic move in September 2023 by acquiring Adivo, a biotechnology company headquartered in Germany, for an undisclosed amount. This acquisition grants Zoetis access to state-of-the-art species-specific antibody libraries and advanced technological expertise. The integration of Adivo's resources positions Zoetis to develop a wide range of cutting-edge veterinary treatments. With the new capabilities from Adivo, Zoetis aims to address unmet needs in companion animals, particularly in areas like cancer treatment, inflammatory disorders, and others. This strategic acquisition further strengthens Zoetis's position in delivering innovative therapeutic antibodies, catering to the evolving demands of its clientele within the veterinary field.

Major companies operating in the animal biotechnology market are Zoetis Inc., Boehringer Ingelheim International GmbH, Biogenesis Bago SA, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated, Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., IDEXX Laboratories Inc., IDVet, Heska Corporation, INDICAL BIOSCIENCE GmbH, BioChek BV, Ceva Sante Animale, Dalan Animal Health, Vetigenics, Vetoquinol S.A., Neogen Corporation, Abaxis Inc., Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Phibro Animal Health Corporation, Novartis Animal Health, Bayer AG, Bioniche Life Sciences Inc., Bio-Rad Laboratories Inc., Biovet JSC, Bovogen Biologicals Pty Ltd.

North America was the largest region in the animal biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the animal biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The animal biotechnology market includes revenues earned by entities by using animal biotechnology for dogs, cats, horses, poultry, swine, cattle, sheep, goats and fish. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Animal Biotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for animal biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The animal biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Diagnostics Tests; Vaccines; Drugs; Reproductive And Genetic; Feed Additives
  • 2) By Animal Type: Companion; Livestock
  • 3) By Application: Diagnosis Of Animal Diseases; Treatment Of Animal Diseases; Preventive Care Of Animals; Drug Development; Other Applications
  • 4) By End-Use: Laboratories; Point-Of-Care Testing Or In-house Testing; Veterinary Hospitals And Clinics; Other End-Uses
  • Subsegments:
  • 1) By Diagnostics Tests: Immunodiagnostic Tests; Molecular Diagnostic Tests; Biochemical Diagnostic Tests
  • 2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines
  • 3) By Drugs: Antimicrobial Drugs; Anti-Inflammatory Drugs; Hormonal Drugs
  • 4) By Reproductive And Genetic: Genetic Testing Services; Artificial Insemination Products; Embryo Transfer Technologies
  • 5) By Feed Additives: Probiotics; Enzymes; Nutraceuticals
  • Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim International GmbH; Biogenesis Bago SA; Merck & Co Inc.; Virbac
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Animal Biotechnology Market Characteristics

3. Animal Biotechnology Market Trends And Strategies

4. Animal Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Animal Biotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Animal Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Animal Biotechnology Market Growth Rate Analysis
  • 5.4. Global Animal Biotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Animal Biotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Animal Biotechnology Total Addressable Market (TAM)

6. Animal Biotechnology Market Segmentation

  • 6.1. Global Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics Tests
  • Vaccines
  • Drugs
  • Reproductive And Genetic
  • Feed Additives
  • 6.2. Global Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Companion
  • Livestock
  • 6.3. Global Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnosis Of Animal Diseases
  • Treatment Of Animal Diseases
  • Preventive Care Of Animals
  • Drug Development
  • Other Applications
  • 6.4. Global Animal Biotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratories
  • Point-Of-Care Testing/In-house Testing
  • Veterinary Hospitals And Clinics
  • Other End-Uses
  • 6.5. Global Animal Biotechnology Market, Sub-Segmentation Of Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunodiagnostic Tests
  • Molecular Diagnostic Tests
  • Biochemical Diagnostic Tests
  • 6.6. Global Animal Biotechnology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • 6.7. Global Animal Biotechnology Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antimicrobial Drugs
  • Anti-Inflammatory Drugs
  • Hormonal Drugs
  • 6.8. Global Animal Biotechnology Market, Sub-Segmentation Of Reproductive and Genetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing Services
  • Artificial Insemination Products
  • Embryo Transfer Technologies
  • 6.9. Global Animal Biotechnology Market, Sub-Segmentation Of Feed Additives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Probiotics
  • Enzymes
  • Nutraceuticals

7. Animal Biotechnology Market Regional And Country Analysis

  • 7.1. Global Animal Biotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Animal Biotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Animal Biotechnology Market

  • 8.1. Asia-Pacific Animal Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Animal Biotechnology Market

  • 9.1. China Animal Biotechnology Market Overview
  • 9.2. China Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Animal Biotechnology Market

  • 10.1. India Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Animal Biotechnology Market

  • 11.1. Japan Animal Biotechnology Market Overview
  • 11.2. Japan Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Animal Biotechnology Market

  • 12.1. Australia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Animal Biotechnology Market

  • 13.1. Indonesia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Animal Biotechnology Market

  • 14.1. South Korea Animal Biotechnology Market Overview
  • 14.2. South Korea Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Animal Biotechnology Market

  • 15.1. Western Europe Animal Biotechnology Market Overview
  • 15.2. Western Europe Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Animal Biotechnology Market

  • 16.1. UK Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Animal Biotechnology Market

  • 17.1. Germany Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Animal Biotechnology Market

  • 18.1. France Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Animal Biotechnology Market

  • 19.1. Italy Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Animal Biotechnology Market

  • 20.1. Spain Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Animal Biotechnology Market

  • 21.1. Eastern Europe Animal Biotechnology Market Overview
  • 21.2. Eastern Europe Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Animal Biotechnology Market

  • 22.1. Russia Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Animal Biotechnology Market

  • 23.1. North America Animal Biotechnology Market Overview
  • 23.2. North America Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Animal Biotechnology Market

  • 24.1. USA Animal Biotechnology Market Overview
  • 24.2. USA Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Animal Biotechnology Market

  • 25.1. Canada Animal Biotechnology Market Overview
  • 25.2. Canada Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Animal Biotechnology Market

  • 26.1. South America Animal Biotechnology Market Overview
  • 26.2. South America Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Animal Biotechnology Market

  • 27.1. Brazil Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Animal Biotechnology Market

  • 28.1. Middle East Animal Biotechnology Market Overview
  • 28.2. Middle East Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Animal Biotechnology Market

  • 29.1. Africa Animal Biotechnology Market Overview
  • 29.2. Africa Animal Biotechnology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Animal Biotechnology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Animal Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Animal Biotechnology Market Competitive Landscape And Company Profiles

  • 30.1. Animal Biotechnology Market Competitive Landscape
  • 30.2. Animal Biotechnology Market Company Profiles
    • 30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biogenesis Bago SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Virbac Overview, Products and Services, Strategy and Financial Analysis

31. Animal Biotechnology Market Other Major And Innovative Companies

  • 31.1. Elanco Animal Health Incorporated
  • 31.2. Randox Laboratories Ltd.
  • 31.3. Santa Cruz Biotechnology Inc.
  • 31.4. IDEXX Laboratories Inc.
  • 31.5. IDVet
  • 31.6. Heska Corporation
  • 31.7. INDICAL BIOSCIENCE GmbH
  • 31.8. BioChek BV
  • 31.9. Ceva Sante Animale
  • 31.10. Dalan Animal Health
  • 31.11. Vetigenics
  • 31.12. Vetoquinol S.A.
  • 31.13. Neogen Corporation
  • 31.14. Abaxis Inc.
  • 31.15. Henry Schein Animal Health

32. Global Animal Biotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Animal Biotechnology Market

34. Recent Developments In The Animal Biotechnology Market

35. Animal Biotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 Animal Biotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Animal Biotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Animal Biotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer